In the study, they found that the brains of T2D patients who were treated with both insulin and a hypoglycemic medication had 80% lower neuritic plaques in the hippocampus and several cortical regions compared to non-T2D and subjects who received either insulin or a hypoglycemic medication. Here, INS is linked to type 2 diabetes mellitus.